focus -WSS

focus

author：fashion 2025-09-30 21:58:00 - browse：68116

There’s a specter haunting Wall Street.

It started in biotech, where companies making drugs for the obesity-related liver disease NASH saw their valuations crash on the assumption that GLP-1 weight loss treatments would cut them out of the market. Then the Ozempic panic came for dialysis firms, whose stocks fell about 20% in a single day on the news that Novo Nordisk’s medicine had delayed the progression of kidney disease in a study enrolling people with type 2 diabetes.

Now analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs’ growing popularity, said Jared Holz, a health care specialist at Mizuho Securities. Buy Bumble, sell McDonald’s. Short Pepsi, go long Louis Vuitton. Put your money in sectors that cater to a svelte and sated brand of consumer, and get out of the ones that rely on excess and compulsion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Woman gored by Bison at Yellowstone

knowledge

focus

WSS

Blood tests recalled over risk of missed heart attack diagnosis

Listen: Biogen's messy board & Laronde's data problem

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Celiac disease study examines precisely how gluten triggers injury

hotspot

focus

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Care demand spikes challenge UnitedHealth’s provider arm

Hollywood unions extend contract negotiations for actors

When is a doctor not a doctor? Try when patients address women doctors

New air purifier tech could be key to improving indoor air quality

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Supreme Court strikes down use of affirmative action

J&J expands global access to TB drug amid advocacy campaign

State Dept. review finds Biden bears some blame for Afghanistan failures

Connecting traumatic brain injury and domestic violence

leisure time

Involuntary treatment for addiction doesn't work

Blood tests recalled over risk of missed heart attack diagnosis

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Everything to know for the next Powerball drawing as jackpot hits $1 billion

Did the public have the right to know Arthur Ashe had AIDS?

J&J expands global access to TB drug amid advocacy campaign

leisure time

knowledge

focus

explore